CoChat

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy

Bridges, KR, Barabino, GD, Brugnara, C, Cho, MR, Christoph, GW, Dover, G, Ewenstein, BM, Golan, DE, Guttmann, CR, Hofrichter, J, Mulkern, RV, Zhang, B, Eaton, WA · 1996 · Blood

Abstract

During 24 weeks of hydroxyurea treatment, we monitored red blood cell (RBC) parameters in three patients with sickle cell disease, including F-cell and F-reticulocyte profiles, distributions of delay times for intracellular polymerization, sickle erythrocyte adherence to human umbilical vein endothelial cells in a laminar flow chamber, RBC phthalate density profiles, mean corpuscular hemoglobin concentration and cation content, reticulocyte mean corpuscular hemoglobin concentration, 1H-nuclear magnetic resonance transverse relaxation rates of packed RBCs, and plasma membrane lateral and rotational mobilities of band 3 and glycophorins. Hydroxyurea increases the fraction of cells with sufficiently long delay times to escape the microcirculation before polymerization begins. Furthermore, high pretreatment adherence to human umbilical vein endothelial cells of sickle RBCs decreased to normal after only 2 weeks of hydroxyurea treatment, preceding the increase in fetal hemoglobin levels. The lower adhesion of sickle RBCs to endothelium would facilitate escape from the microcirculation before polymerization begins. Hydroxyurea shifted several biochemical and biophysical parameters of sickle erythrocytes toward values observed with hemoglobin SC disease, suggesting that hydroxyurea moderates sickle cell disease toward the milder, but still clinically significant, hemoglobin SC disease. The 50% reduction in sickle crises documented in the Multicenter Study of Hydroxyurea in Sickle Cell Disease is consistent with this degree of erythrocyte improvement.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood.v88.12.4701.bloodjournal88124701

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Cited by

See all 184

Metadata

Authors
Bridges, K., Barabino, G., Brugnara, C., Cho, M., Christoph, G., Dover, G., Ewenstein, B., Golan, D., Guttmann, C., Hofrichter, J., Mulkern, R., Zhang, B., & Eaton, W.
Affiliations
  • Brigham and Women's Hospital (US)
  • Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Venue
Blood
Published
1996-12-15
Volume
88
Issue
12
Pages
4701-4710
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1509226676
Cited by
184
References
46
Citations by year
2026: 4 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 8 · 2019: 7 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 10 · 2014: 8 · 2013: 4 · 2012: 7
FWCI
4.10
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (HL 28028, P60HL015157, HL-32854, HL 15157)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Hematology › Blood properties and coagulation
  • Health Sciences › Medicine › Physiology (medical) › Erythrocyte Function and Pathophysiology
Keywords
sickle cell disease, hydroxyurea therapy, sickle erythrocytes, hemoglobin polymerization, hemoglobin SC disease, band 3 protein, glycophorin, fetal hemoglobin
MeSH terms
Adult, Anion Exchange Protein 1, Erythrocyte, Cell Adhesion, Chlorides, Endothelium, Vascular, Erythrocyte Aggregation, Erythrocytes, Female, Fetal Hemoglobin, Hemoglobin SC Disease, Humans, Hydroxyurea, Male, Magnetic Resonance Spectroscopy, Potassium, Ion Transport

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. https://app.cochat.ai/papers/10.1182/blood.v88.12.4701.bloodjournal88124701
The paper
Bridges, K., Barabino, G., Brugnara, C., Cho, M., Christoph, G., Dover, G., Ewenstein, B., Golan, D., Guttmann, C., Hofrichter, J., Mulkern, R., Zhang, B., & Eaton, W. (1996). A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood. https://doi.org/10.1182/blood.v88.12.4701.bloodjournal88124701

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.